DESolve Post-Approval Study
NCT02013349 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102
Last updated 2020-04-08
Summary
To evaluate the long-term safety and performance of the DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System
Conditions
Interventions
- DEVICE
-
coronary intervention
Sponsors & Collaborators
-
Elixir Medical Corporation
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-22
- Primary Completion
- 2015-10-31
- Completion
- 2019-04-01
Countries
- Germany
- Italy
- Jordan
Study Locations
More Related Trials
-
International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions
NCT01373502 ·Status: COMPLETED ·Phase: NA
-
The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions
NCT05033964 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The SELUTION DeNovo Study
NCT04859985 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
DELIVER Study: DELiverability of the Resolute Integrity Stent in All-Comer Vessels and Cross-OvER Stenting
NCT01297257 ·Status: COMPLETED
-
BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions
NCT01426139 ·Status: COMPLETED ·Phase: NA
-
SELUTION 4 De Novo Small Vessel IDE Trial
NCT05946629 ·Status: RECRUITING ·Phase: NA
-
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions
NCT07091682 ·Status: RECRUITING ·Phase: NA
-
A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary Small Vessel Disease
NCT03376646 ·Status: COMPLETED ·Phase: NA
-
First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease
NCT01247428 ·Status: COMPLETED ·Phase: PHASE2
-
DESyne X2 Post Market Follow-up Study
NCT04375085 ·Status: TERMINATED ·Phase: NA
-
FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study
NCT04591938 ·Status: RECRUITING ·Phase: NA
-
Drug-Coated Balloon in Combination With New Generation Drug-Eluting Stent for de Novo Diffuse Disease Treatment
NCT03939468 ·Status: UNKNOWN
-
Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"
NCT00792753 ·Status: COMPLETED ·Phase: NA
-
Medtronic RevElution Trial
NCT02480348 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary In-stent Restenosis
NCT03373695 ·Status: COMPLETED ·Phase: NA
-
Prospective, Multi-Center, Random. Study of CoStar Paclitaxel-Eluting Coronary Stent(Direct Stenting vs. Pre-Dilatation)
NCT00440674 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES
NCT03399994 ·Status: COMPLETED ·Phase: NA
-
Clinical Study Protocol - Debris Interventional Removal in ACS (DESIRE-ACS)
NCT02325869 ·Status: UNKNOWN ·Phase: NA
-
Prospective multicEntric NonranDomized Registry
NCT02496169 ·Status: UNKNOWN ·Phase: NA
-
RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries
NCT01150500 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of the DEVOIR Sirolimus-Coated Coronary Balloon in the Real-world Clinical Practice
NCT02853994 ·Status: UNKNOWN
-
Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)
NCT06086496 ·Status: ENROLLING_BY_INVITATION
-
Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions
NCT07022587 ·Status: RECRUITING ·Phase: NA
-
Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global
NCT04236609 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
NCT00638794 ·Status: COMPLETED